Then Google it. Pop that question to Alphabet's (GOOGL) search engine giant and the first answer you're likely to get is ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

From a trailing price-to-earnings (P/E) ratio standpoint, Alphabet hasn't been this cheap since the beginning of 2023, when ...

Sundar Pichai, Alphabet's CEO, sold $5.15 million in Class C stock under a pre-arranged trading plan as the company's shares ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The technology sector is disruptive and driven by innovation. This means that a market leader today may become irrelevant ...

Alphabet is the parent company of Google, YouTube, Android, and other subsidiaries under the Alphabet umbrella. Although its business is quite broad, about 75% of Alphabet's revenue comes from ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...

Then Google it. Pop that question to ... do in 1993 when the Man of Steel came back from the dead. Alphabet CEO Sundar Pichai's company is contending with increased competition and an economic ...

The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google’s parent ... design engine and support the company’s goal of bringing ...

The bloodbath in the markets in the wake of President Donald Trump's new tariffs hit Elon Musk's Tesla especially hard Friday, knocking the price down over 10% and evaporating with it a chunk of the ...